These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20868205)

  • 21. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction.
    Saito T; Kuang JQ; Lin CC; Chiu RC
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):114-23. PubMed ID: 12878946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered early embryonic cardiac tissue increases cardiomyocyte proliferation by cyclic mechanical stretch via p38-MAP kinase phosphorylation.
    Clause KC; Tinney JP; Liu LJ; Keller BB; Tobita K
    Tissue Eng Part A; 2009 Jun; 15(6):1373-80. PubMed ID: 19196150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic Resonance Imaging of Cardiac Strain Pattern Following Transplantation of Human Tissue Engineered Heart Muscles.
    Qin X; Riegler J; Tiburcy M; Zhao X; Chour T; Ndoye B; Nguyen M; Adams J; Ameen M; Denney TS; Yang PC; Nguyen P; Zimmermann WH; Wu JC
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitotically inactivated embryonic stem cells can be used as an in vivo feeder layer to nurse damaged myocardium after acute myocardial infarction: a preclinical study.
    Burt RK; Chen YH; Verda L; Lucena C; Navale S; Johnson J; Han X; Lomasney J; Baker JM; Ngai KL; Kino A; Carr J; Kajstura J; Anversa P
    Circ Res; 2012 Oct; 111(10):1286-96. PubMed ID: 22914647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.
    Zimmermann WH; Melnychenko I; Wasmeier G; Didié M; Naito H; Nixdorff U; Hess A; Budinsky L; Brune K; Michaelis B; Dhein S; Schwoerer A; Ehmke H; Eschenhagen T
    Nat Med; 2006 Apr; 12(4):452-8. PubMed ID: 16582915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic culture yields engineered myocardium with near-adult functional output.
    Jackman CP; Carlson AL; Bursac N
    Biomaterials; 2016 Dec; 111():66-79. PubMed ID: 27723557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium.
    Miyagawa S; Sawa Y; Sakakida S; Taketani S; Kondoh H; Memon IA; Imanishi Y; Shimizu T; Okano T; Matsuda H
    Transplantation; 2005 Dec; 80(11):1586-95. PubMed ID: 16371930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance.
    Berry MF; Engler AJ; Woo YJ; Pirolli TJ; Bish LT; Jayasankar V; Morine KJ; Gardner TJ; Discher DE; Sweeney HL
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2196-203. PubMed ID: 16473959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization.
    Masumoto H; Matsuo T; Yamamizu K; Uosaki H; Narazaki G; Katayama S; Marui A; Shimizu T; Ikeda T; Okano T; Sakata R; Yamashita JK
    Stem Cells; 2012 Jun; 30(6):1196-205. PubMed ID: 22438013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue.
    Radisic M; Park H; Martens TP; Salazar-Lazaro JE; Geng W; Wang Y; Langer R; Freed LE; Vunjak-Novakovic G
    J Biomed Mater Res A; 2008 Sep; 86(3):713-24. PubMed ID: 18041719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation.
    Retuerto MA; Schalch P; Patejunas G; Carbray J; Liu N; Esser K; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1041-9; discussion 1049-51. PubMed ID: 15052201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular cardiomyoplasty improves survival after myocardial injury.
    Roell W; Lu ZJ; Bloch W; Siedner S; Tiemann K; Xia Y; Stoecker E; Fleischmann M; Bohlen H; Stehle R; Kolossov E; Brem G; Addicks K; Pfitzer G; Welz A; Hescheler J; Fleischmann BK
    Circulation; 2002 May; 105(20):2435-41. PubMed ID: 12021233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of bioartificial myocardial graft survival and engraftment in vivo.
    Mueller-Stahl K; Kofidis T; Akhyari P; Lee DH; Lenz A; Martinez EC; Woitek F; Haverich A
    J Heart Lung Transplant; 2008 Nov; 27(11):1242-50. PubMed ID: 18971098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.
    Kawamura M; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura T; Kuratani T; Daimon T; Shimizu T; Okano T; Sawa Y
    Circulation; 2012 Sep; 126(11 Suppl 1):S29-37. PubMed ID: 22965990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction.
    Li Q; Turdi S; Thomas DP; Zhou T; Ren J
    Toxicol Lett; 2010 Jun; 195(2-3):119-26. PubMed ID: 20303399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets.
    Shimizu T; Sekine H; Isoi Y; Yamato M; Kikuchi A; Okano T
    Tissue Eng; 2006 Mar; 12(3):499-507. PubMed ID: 16579683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of matrix (an)isotropy on cardiomyocyte contraction in engineered cardiac microtissues.
    van Spreeuwel AC; Bax NA; Bastiaens AJ; Foolen J; Loerakker S; Borochin M; van der Schaft DW; Chen CS; Baaijens FP; Bouten CV
    Integr Biol (Camb); 2014 Apr; 6(4):422-9. PubMed ID: 24549279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.
    Caspi O; Huber I; Kehat I; Habib M; Arbel G; Gepstein A; Yankelson L; Aronson D; Beyar R; Gepstein L
    J Am Coll Cardiol; 2007 Nov; 50(19):1884-93. PubMed ID: 17980256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
    Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities.
    Birla R; Dhawan V; Huang YC; Lytle I; Tiranathanagul K; Brown D
    Artif Organs; 2008 Sep; 32(9):684-91. PubMed ID: 18684210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.